In October 2020, we entered into a license agreement with Nevakar for an exclusive license to develop, manufacture, register, import and commercialize NVK-002 in Greater China, South Korea and certain countries in Southeast Asia.
ZHAOKE
ZHAOKE
IACTA
In July 2020, we entered into a license agreement with IACTA for the license of certain patents and know-how relating to IC-265 and IC-270 in Greater China and certain Southeast Asia countries.
TOT BIOPHARM.
In January 2017 and April 2020, we entered into a series of product licensing, development and commercialization agreements with TOT BIOPHARM, under which TOT BIOPHARM granted us an exclusive license to commercialize TAB014 for neovascularization-related
REX
ZHAOKE IPOI
NTC
In December 2020, we entered into a license and supply agreement with NTC, and we were granted an exclusive license to develop, import, register, obtain price and seek reimbursement, promote, market, distribute and sell NTC014 in Greater China, South Kore
